6th Clinical Trials Inspection Readiness Summit

As clinical trials are conducted, inspections ensure quality and integrity of care, data and drug performance. As sponsors for clinical trials, pharmaceutical companies are required to ensure GCP guidelines are upheld by implementing inspection readiness. These inspections are conducted by regulatory authorities, which all have unique regulations and caveats. These nuances make inspection readiness a difficult and resource-consuming battle. Clinical trials must be prepared for visits from countless stakeholders over their course. At the 6th Clinical Trials Inspection Readiness Summit, you will understand the importance of an organizational culture of inspection readiness and how to implement that cultural change.


Ivan Walrath, Pamela Perry, Lou Pasquale, Dawn M. Niccum, Tipsuda Kongtong, Ellen Kelso, Andreas Kateifides, Alyssa K. Gateman, Betsy Fallen, Stephanie deRijke, Linda M. Coleman, Nancy Bitters, Angela Berns, Stacey L. Basham

Go to event website